This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 24

Based on the information you provided, we found the following studies.

  • Neratinib for Patients with HER2 + Breast Cancer and Brain Metastases The purpose of this research study is to determine how well neratinib works in treating breast cancer that has spread to the brain. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Prospective study evaluating the use of PROSPECT, a cognitive behavioral therapy-based internet module, to reduce insomnia in patients with early stage breast cancer Prospective study evaluating the use of PROSPECT, a cognitive behavioral therapy-based internet module, to reduce insomnia in patients with early stage breast cancer This study is researching all of the following topics: Breast cancer Insomnia This study is looking for: female only women Volunteers with specific conditions
    • All ages welcome
  • A First-In-Human Study of Dosing with REGN2810 as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies Study purpose: find safe dose of REGN2810 given alone or in combination therapies;measure levels of REGN2810 in blood; evaluate if REGN2810 given alone or in combination w/other therapies will cause tumor shrinkage;test different dose levels of REGN2810, radiotherapy, GM-CSF, and cyclophosphamide. This study is researching all of the following topics: Bladder cancer Breast cancer Cervical cancer Colorectal / Colon / Rectal cancer Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Stomach cancer, Gastric cancer ( Malignant tumor of stomach ) Thyroid cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Ph Ib/II trial of investigational drug taselisib (GDC-0032), a PI3K inhibitor, in combination with enzalutamide in subjects with androgen receptor positive triple negative metastatic breast cancer Ph 1b purpose: test safety of GDC-0032 when taken with enzalutamide.Ph II purpose: test how well GDC-0032 works to keep cancer from growing when taken with enzalutamide compared to taking enzalutamide only.GDC-0032 inhibits a protein that may be involved in the growth and spread of some cancers. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Characteristics and Mechanisms of Cognitive Problems in Fibromyalgia Cognitive “fog" (slow and/or foggy thinking) is a very serious and common problem for people with different conditions such as fibromyalgia, depression, cancer, and multiple sclerosis. This study seeks to open a window onto the nature of cognitive fog in adults with these conditions. This study is researching all of the following topics: Breast cancer Depression Fibromyalgia Multiple sclerosis This study is looking for: male female both men and women Volunteers with specific conditions
    • 18 years to 60 years
  • Phase II study of ponatinib for advanced cancers with genomic alterations in fibroblastic growth factor receptor (FGFR) and other genomic targets (KIT, PDGFRa, RET FLT3, ABL1) The purpose of this study is to find out what effects; good and/or bad, ponatinib has on you and your cancer. Your body has proteins that are involved in a cancer’s ability to grow and survive. The drug, Ponatinib, may prevent these proteins from causing cancer growth. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Randomized Phase II Study of Adjuvant Trastuzumab emtansine (T-DM1) vs Paclitaxel in Combination with Trastuzumab (Herceptin®) for Stage I HER2-Positive Breast Cancer Goals: see if T-DMl will have less side-effects than traditional HER2-positive breast cancer treatment of trastuzumab + paclitaxel; learn about the long term benefits and disease-free survival of subjects who take T-DM1 compared to those subjects to take the combination of trastuzumab + paclitaxel. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Randomized, Double-blind, Placebo-controlled Ph 2 Study of Paclitaxel in Combination with Reparixin Compared to Paclitaxel Alone as Front-line Therapy for Metastatic Triple-Negative Breast Cancer The main objective of this study is to compare the combination of paclitaxel plus new experimental drug reparixin, to paclitaxel without reparixin. This study will look for differences in both safety and effectiveness. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 2 Study of investigational drug Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer This study is being done to see how safe abemaciclib is and how well it will work to help people with breast cancer that has spread to the brain. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • More than 18 years old
  • Radium-223 dichloride vs. placebo when administered to metastatic HER2 negative hormone receptor positive breast cancer w/bone metastases treated w/hormonal treatment background therapy. (Bayer 16298) The study goal is to understand if adding radium-223 dichloride to the standard of care hormonal therapy helps subjects to survive longer with a delay in the occurrence of symptomatic skeletal events (SSEs).Radium-223 dichloride is considered an experimental drug for subjects with breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 24 studies
Show more studies